Feature Stories
English
|
French
2008
|
2007
|
2006
|
2005
|
2004
2008
November
DFID Event Galvanizes Support for New HIV Prevention Technologies
August
Spain Contributes €1.5 Million to Global Efforts to Help Women Protect Themselves from HIV
IPM Research Featured in Groundbreaking HIV Resource
June
IPM and UN Diplomats Discuss HIV Prevention Research
IPM Discusses Microbicide Development with Austrians
March
Microbicide Developer Receives License for Novel HIV Microbicide Candidate from Merck & Co., Inc.
Final Summary of SAB Executive Committee Meeting December 4, 2007
IPM’s Work Featured at International Gathering of Microbicide Researchers, Advocates
February
Zeda Rosenberg Statement on Carraguard and PRO 2000 Microbicide Trials
January
IPM and Pfizer Agree to Develop FDA Approved Antiretroviral Drug Maraviroc as a Vaginal Microbicide
2007
November
World AIDS Day 2007
August
New Report on Lessons from the Introduction of Contraceptive Technologies
July
2006 Annual Report Now Available
June
Microbicides to be Featured at World YWCA's International Women's Summit
New Address for IPM's U.S. Office
Microbicides Highlighted in Infectious Disease Journal
March
Women Need Better Tools for Preventing HIV
January
Statement from IPM’s CEO on the Closing of Cellulose Sulfate Gel Trials
EC Commits €4.2 million to Microbicide Development
2006
December
Statement from IPM’s CEO on Findings that Adult Male Circumcision Significantly Reduces Risk of Acquiring HIV
Canada Commits CAD15 Million to Accelerate Microbicide Development
HRH Princess Astrid of Belgium Hosts World AIDS Day Luncheon Featuring Microbicides
November
IPM Lauds the Netherlands for Renewed Commitment to Developing Tools to Protect Women from HIV
August
Microbicides at the XVI International AIDS Conference
Toronto, Canada, August 13-18, 2006
IPM Hosts Consultation on Microbicide Introduction in Africa and India
July
G8 Pledges to Fight Infectious Disease
May
UNGASS + 5 and Microbicides
IPM CEO on CNN’s “The End of AIDS: A Global Summit with Bill Clinton”
April
Microbicides 2006 Conference Speeches and Scientific Summaries Available
Issue Brief on IPM Clinical Trials
2005
December
Nearly US$30 Million Committed to Microbicide Development
November
Drug Company Support is Critical to Advancing AIDS Prevention Effort: Statement by IPM CEO, Dr. Zeda Rosenberg, on New AIDS Statistics
October
IPM Signs Drug Licensing Agreements with Merck and Bristol-Myers Squibb
Arizona Health Leaders Gather in Tucson to Discuss New Methods for Protecting Women from HIV
Microbicides Briefing in Brussels, Belgium
September
New Policy Paper from IPM
July
IPM 2004 Annual Report Now Available
Chicago Public Radio – Worldview: Radio interview with Dr. Zeda Rosenberg
June
IPM joins health industry and drug development colleagues in appeal to the G8 to support product development for neglected diseases
Kofi Annan Voices Support for Microbicides and Vaccines
May
IPM Conducts Microbicides Briefing in Mozambique
Apr
il
IPM Hosts Donors Meeting in London
March
IPM, the Global Campaign for Microbicide and the Alliance for Microbicide Development issue a call to the G8 leaders
IPM's Dr. Oguda to Participate in a Panel
IPM CEO Joins UNAIDS-Sponsored Panel
February
A Briefing for Global Treatment Activists
2004
November
World AIDS Day 2004
IPM Headquarters: 8401 Colesville Road • Suite 200 • Silver Spring, MD 20910
(p) +1 301-608-2221 • (f) +1 301-608-2241
© Copyright 2008, International Partnership for Microbicides